Literature DB >> 4158837

Potassium chloride and intestinal ulceration.

V Wynn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 4158837     DOI: 10.1016/s0140-6736(65)90671-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Formulation, bioavailability, and pharmacokinetics of sustained-release potassium chloride tablets.

Authors:  S Senel; Y Capan; T Dalkara; N Inanç; A A Hincal
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

2.  Complications of "slow-K" therapy.

Authors:  F Sandor
Journal:  J R Coll Gen Pract       Date:  1976-08

3.  Letter: Mouth ulceration and slow-release potassium tablets.

Authors:  B R McAvoy
Journal:  Br Med J       Date:  1974-10-19

4.  Potassium supplements.

Authors:  B E Nordin; R Wilkinson
Journal:  Br Med J       Date:  1970-02-14

5.  An acceptable slow-release phosphate preparation "slow P".

Authors:  V Parsons; A Porter; C Lund
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

6.  Potassium supplements.

Authors:  H E De Wardener; E M Clarkson; J Ford
Journal:  Br Med J       Date:  1969-10-18

7.  Potassium chloride and bowel ulceration.

Authors:  V Wynn
Journal:  Br Med J       Date:  1965-12-25

8.  Kinetics of potassium excretion following oral supplements: evidence of induced natriuresis.

Authors:  A Rakhit; S Melethil; J D Arnold; W E Wagner
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

9.  Pharmacokinetics of potassium chloride in wax-based and syrup formulations.

Authors:  J M Toner; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.